Federal agency to re-examine U.S. stem cell patents
<p class="source">The San Jose Mercury News (California)</p>
<p>Patent examiners said in recent rulings that the claims by the Foundation for Taxpayer and Consumer Rights (FTCR) and the Public Patent Foundation (PUBPAT) raise substantial new questions about whether the patents are valid.
"We take that as a positive thing," said John Simpson of the California-based FTCR. "We obviously would like to see them completely revoked because the way they are being asserted right now is an impediment to research."</p>
